Sponsor content
272 result(s) found, displaying 31 to 40
-
Australian Public Assessment Report (AusPAR)Opsynvi (macitentan/tadalafil) is approved for maintenance treatment of pulmonary arterial hypertension in adult patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 90 mg/ 1 mL solution for injection pre-filled pen (One-Press patient-controlled injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TALVEY talquetamab 40 mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TALVEY talquetamab 2 mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 5.0 mg/1 mL solution for intravenous infusion injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SETRELVO ustekinumab 90 mg/1 mL solution for injection pre-filled syringe.